Humanin

Kanaka

Kanaka

ʻO Humanin kahi peptide i hoʻopaʻa ʻia i ka mitochondrial 24 nā ʻakika amino; ʻike mua ʻia i loko o ka pōʻaiapili o ka noiʻi maʻi o Alzheimer.

Pane wikiwiki

Humanin is a unique mitochondrial-derived bioactive peptide with powerful neuronal defense and cell anti-apoptosis properties. Widely applied in neurodegeneration and longevity research, available for bulk laboratory supply and biotech formulation studies.

SKU: 198904 Māhele:
Kaʻana like i kāu aloha

ʻO Humanin kahi peptide i hoʻopaʻa ʻia i ka mitochondrial 24 nā ʻakika amino; ʻike mua ʻia i loko o ka pōʻaiapili o ka noiʻi maʻi o Alzheimer.

I nā maʻi o Alzheimer, ka hōʻike ʻana iā Humanin i loko o nā cell a i ʻole ka hoʻohui ʻana iā ia ma ke ʻano he peptide endogenous e pale i kēia mau neurons mai nā ʻano pōʻino e pili ana iā Alzheimer. – ʻO nā hopena neuroprotective koʻikoʻi ka ʻike mua i hana ʻia.

Hoʻoikaika ʻo Humanin i nā ala ola ola kino, ka JAK2/STAT3/ACT he mau kumu hoʻohālike, kaohi pono ʻana i nā ala apoptotic hilinaʻi mitochondrial; Aβ, ischemia-hypoxia, a me nā ʻano ʻano koʻikoʻi oxidative ʻo ia ka mea i ʻōlelo ʻia.

ʻO ka hoʻonui ʻana i ka antioxidant cellular a me ka nui o nā hiki anti-inflammatory kahi hopena i kākau maikaʻi ʻia.

Kaʻina

Met - Ala - Pro - ʻO Arg - ʻO Gly - Ua haʻi aku ʻo Phe - E lilo - Cys - Leu - Leu - Leu - Leu - ʻO Thr - E lilo - ʻO Glu - Me - ʻO Asp - Leu - Pro - ʻO Val - Lys - ʻO Arg - ʻO Arg - Ala

Helu CAS

330936-69-1

ʻĀpana Molekala

C119H204N34O32S2

Kaumaha Molekala

2687.27

Noiʻi pili i ka Humanin

1.Nā Hoʻohana Hoʻomaʻamaʻa Lapaʻau

Nā hana koʻikoʻi i ka hoʻolaha ʻana ka metabolism glucose, ka hoʻomaikaʻi ʻana i kekahi ʻano o ʻike i ka insulin, a ua hōʻike ʻia ka pale ʻana i nā kīʻaha koko.

No laila he peptide pale endogenous e like me Humanin paʻa i ka mana nui no ka mālama ʻana (a i ʻole ka hoʻomaikaʻi ʻana) pili makahiki nā maʻi degenerative; Ke ʻimi ʻia nei nā lāʻau lapaʻau anti-aging a ʻoi aku ka maikaʻi ma muli o kēia laina o ka noiʻi.

2.Nā Hana Hoʻomalu Metabolic a me Vascular

ʻO nā hana koʻikoʻi i ka hāpai ʻana i ka metabolism glucose, ka hoʻomaikaʻi ʻana i kekahi ʻano o ka ʻike insulin, a ua hōʻike ʻia ka pale ʻana i nā kīʻaha koko.

No laila he peptide pale endogenous e like me Humanin paʻa i ka mana nui no ka mālama ʻana (a i ʻole ka hoʻomaikaʻi ʻana) nā maʻi degenerative pili makahiki; Ke ʻimi ʻia nei nā lāʻau lapaʻau anti-aging a ʻoi aku ka maikaʻi ma muli o kēia laina o ka noiʻi.

3.Nā hopena neuroprotective

ʻO ka kū'ē pololei o ka β-amyloid toxicity ka mea e wehewehe ai i ka hana neuroprotective a Humanin. – ʻO ka hōʻuluʻulu a me ka waiho ʻana o ka Aβ ma hope o nā kumu nui i ka hoʻomaka ʻana o ka maʻi.

Hoʻoikaika ka mea hoʻokipa i kēlā mau ala ola intracellular i haʻi mua ʻia.

Kāohi nā hōʻailona mai Humanin i nā ala apoptosis i ʻōlelo ʻia, hoʻopaʻa ʻia nā protein hoʻokō; Ua pale ʻia ka make neuronal programmed.

Ma waho aʻe o Aβ, nā maʻi neurological degenerative (ʻo Parkinson, ko Huntington ʻike ʻia) hōʻike like, ina aole like, Nā pōmaikaʻi neuroprotective mai Humanin.

ʻO ka pale ʻana i ka maʻi cardiovascular kahi mea nui o ka waiwai therapeutic o Humanin.

ʻO ka hoʻomohala ʻana o Humanin ma ke ʻano he therapeutic agent kahi holomua koʻikoʻi i ka ʻepekema olakino.

4.Antioxidant a me Anti-Apoptotic hopena

ʻO ke kumu o Humanin, ʻO ka hana koʻikoʻi ka pale ʻana i ka apoptosis cell maʻamau i hoʻoulu ʻia e ke kaumaha nui.

ʻO ke koʻikoʻi oxidative nui a ma hope o kēia ʻano apoptosis kekahi o nā kumu kumu o nā maʻi like ʻole a me nā kūlana pili makahiki āpau..

Hoʻonui ʻo Humanin i ka hana koʻikoʻi antioxidant i loko o nā cell tissue; kū'ē i ka hoʻokuʻu ʻana o ka mitochondrial cytochrome C ʻo ia kekahi ʻāpana nui o kēia kaʻina hana. Hoʻopau kēia hana physiological ikaika i ka hoʻomaka ʻana o nā ala apoptosis intrinsic, ʻO ka pōʻino oxidative ka mea e hopohopo nui ai.

ʻIke ʻia, ʻO ka hopena o ka hoʻopaʻa ʻana o ka cell a Humanin ma mua o nā pūnaewele kiko kikoʻī wale nō – ka pale ʻana i nā ʻano like ʻole e kūʻē i ke koʻikoʻi oxidative nui a me nā ʻano āpau o ia apoptosis, ʻo ia ka mea a Humanin e hoʻolako ai; ʻike ʻia ka hoʻohana ākea o kēia pale.

5.Hoʻoponopono kino

He koʻikoʻi ko Humanin i ka hoʻoponopono ʻana i ka homeostasis metabolic systemic, ʻO ke kūpaʻa kelepona kekahi o kāna mau hopena i ʻike pololei ʻia. ʻO ka glucose metabolism kahi hiʻohiʻona nui.

Ua hōʻike ʻia nā hoʻokolohua haʻahaʻa haʻahaʻa o ke kanaka ma ke ʻano 2 nā maʻi maʻi diabetes.

Hoʻonui maikaʻi ka hoʻohui ʻana i ka humanin ka hoʻomanawanui glucose; palekana o ka pancreatic β-cells (apoptosis manuahi) a me keia, ka hana ʻana o ka insulin e pili pono ana.

ʻO kahi ala lapaʻau hou no ka maʻi diabetes a pili metabolic syndromes, Hōʻike ʻo humanin i nā kuhikuhi hoʻohiki no ka lāʻau lapaʻau.

COA

HPLC

MS

(1) ʻO Chiba, Ua ʻōlelo ʻo T.; ʻo Yamada, M.; Makaʻu mākou, J.; Terashita, K.; Shimoda, M.; Matsuoka, M.; Aiso, S. Hoʻopilikia ʻo Amyloid-β i ka hoʻomanaʻo ʻana ma ka hoʻopilikia ʻana i ka axis JAK2/STAT3 i nā neurons hippocampal.. Molecular Psychiatry 2008, 14 (2), 206-222. DOI: 10.1038/mp.2008.105.

(2) Pōʻalima, H.; Bossaller, L.; Pokukala, K.; Pukuahi, B.; Lotz, M.; Flemming, A.; ʻO Schrappe, M.; Postulate, V.; Riikonen, P.; Makaʻu, J.; et al. ʻO ka hemahema o ka mea hoʻopili SLP-65 i ka maʻi leukemia lymphoblastic acute ma mua o ka B-cell. ʻAno 2003, 423 (6938), 452-456. DOI: 10.1038/ʻano01608.

(3) ʻO Ren, L.; Li, Q.; Zeng, Z.; Mou, P.; Liu, X.; Tang, X.; Ua olelo mai o Lu, Q.; ʻO Xu, X.; ʻO Zhu, L. Hoʻopau ka Humanin Analog i nā pane platelet i ka hōʻeha vascular. Koko 2011, 118 (21), 1131-1131. DOI: 10.1182/koko.V118.21.1131.1131.

(4) Thummmasorn, S.; Shinlapawittayatorn, K.; Chattipakorn, S.; Chattipakorn, N. Hoʻohana ʻia ʻo Humanin Analogue kiʻekiʻe i ka wā Ischemia e hāʻawi i ka Cardioprotection e kūʻē i ka Ischemia-Reperfusion Injury ma o ka Attenuating Mitochondrial Dysfunction. Ka Nupepa o ka American College of Cardiology 2017, 69 (11). DOI: 10.1016/s0735-1097(17)33601-x.

(5) Keane, L.; ʻo Perez, M. P.; Friess, L.; Joseph, B. Tmic-74. Hoʻoponopono hou ʻia ʻo Microglia i nā ʻāina hoʻōla anti-Tumoral ma Diffuse Midline Glioma, H3k27 Mutant. Neuro-Oncology 2022, 24 (Pākuʻi_7), vii288-vii288. DOI: 10.1093/neuonc/noac209.1117.

(6) Hoang, P. Ua ʻōlelo ʻo T.; Pāka, P.; ʻO Cobb, L. J.; Paharkova-Vatchkova, V.; Lunakanawai, M.; ʻO Cohen, P.; Lee, K.-W. ʻO ka mea neurosurvival ʻo Humanin ke kāohi i ka β-cell apoptosis ma o ka transducer hōʻailona a me ka mea hoʻoulu o ka transcription 3 ho'āla a hoʻopaneʻe a hoʻomaikaʻi i ka maʻi diabetes i nā ʻiole maʻi diabetes nonobese. ʻO ka metabolism 2010, 59 (3), 343-349. DOI: 10.1016/j.metabol.2009.08.001.

Kaʻina:

Met – Ala – Pro – ʻO Arg – ʻO Gly – Ua haʻi aku ʻo Phe – E lilo – Cys – Leu – Leu – Leu – Leu – ʻO Thr – E lilo – ʻO Glu – Me – ʻO Asp – Leu – Pro – ʻO Val – Lys – ʻO Arg – ʻO Arg – Ala

CAS:

330936-69-1

M.W:

2687.27 g/mol

Home Huli Whatsapp Nā lawelawe Huahana